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P R E V I E W SThe mitochondria and insulin release:
Nnt just a passing relationship
Nicotinamide nucleotide transhydrogenase (Nnt) detoxifies reactive oxygen species (ROS), byproducts of mitochondrial
metabolism that, when accumulated, can decrease mitochondrial ATP production. In this issue of Cell Metabolism, Free-
man et al. (2006) demonstrate that Nnt in pancreatic b cells is important for insulin release. Their compelling data highlight
the critical roles for ATP generation and subsequent closure of KATP channels for insulin secretion.Insulin is synthesized in b cells of pancre-
atic islets and is secreted in response to
elevation in blood sugars. By stimulating
glucose uptake in peripheral tissues, in-
sulin promotes the storage of carbohy-
drates and regulates blood glucose lev-
els. Type 2 diabetes is characterized
by a persistently elevated blood glucose
level and is caused, in part, by impaired
insulin release from pancreatic b cells.
Thus, understanding the etiology of
type 2 diabetes as well as pharmaceuti-
cal approaches to treat the disorder re-
quires a detailed knowledge of how the
b cell senses and metabolizes glucose.
In this issue of Cell Metabolism, Freeman
and colleagues shed new light on the is-
sue by describing a role for diminished
mitochondrial Nnt activity as causal in
suppressed insulin release from pancre-
atic b cells.
The b cell uniquely couples changes in
cellular metabolism to electrical activity,
and thus insulin release (Figure 1). Under
conditions of low glucose, KATP channels
provide the dominant b cell membrane
conductance,maintaining themembrane
in a hyperpolarized state. However, in
the fed state, glucose enters the b cell
through glucose transporters (GLUTs)
and is rapidly metabolized, causing a
rise in the cytoplasmic [ATP]/[ADP] ratio.
This in turn causes closure of ATP-sensi-
tive K+ channels (KATP) at the cell surface,
leading to membrane depolarization
and opening of voltage-dependent Ca2+
channels (VDCCs). Calcium influx results
in a rise in intracellular calcium, which
triggers exocytosis of insulin vesiclesCELL METABOLISM : JANUARY 2006docked at the plasma membrane. This
model of excitation-secretion coupling
highlights the critical role of [ATP]/[ADP]
ratio in translating changes inmetabolism
to changes in electrical activity.
Mitochondrial metabolism accounts
for 95% of ATP production in the b cell
and factors that impairmitochondrial me-
tabolism are expected to decrease the
[ATP]/[ADP] ratio, prevent depolariza-
tion-driven Ca2+ influx, and thereby sup-
press insulin release. Previously, Toye
et al. (2005) mapped mutations in several
candidate genes that are postulated to
underlie the glucose intolerance and im-
paired b cell function that is characteristic
of inbred C57BL/6J mice. One of the mu-
tated genes is Nicotinamide nucleotide
transhydrogenase (Nnt), a nuclear-en-
coded mitochondrial protein involved in
detoxification of reactive oxygen species
(ROS) (Hoek and Rydstrom, 1988). Mito-
chondrial metabolism leads to the gener-
ation of ROS byproducts which, when el-
evated, can have deleterious effect on
mitochondrial ATP production. Detoxifi-
cation of ROS is necessary for normal mi-
tochondria function, and this process
requires a constant supply of NADPH,
generated by Nnt enzymatic activity.
Therefore, mutations in Nnt that diminish
its activity are expected to indirectly sup-
press insulin secretion, by uncoupling
proton-motive ATP production and thus
preventing the ATP-mediated closure of
KATP channels.
In the current study, Freeman et al.
(2006) provide compelling evidence for
diminished mitochondrial Nnt activity ascausal in suppressed insulin release from
pancreatic b cells. First, in MIN6 cells, an
insulin-secreting b cell line, knockdown
of endogenous Nnt activity is sufficient
to block the glucose-dependent rise in
intracellular Ca2+, the ‘‘trigger’’ for insulin
release. Second, the authors identify two
novel Nnt mutations in an ENU (ethylni-
trosourea)-mutagenized mouse archive.
Importantly, re-derivedhomozygousNnt-
mutated mice recapitulate the character-
istic features of C57BL/6J mice and are
glucose intolerant and hypoinsulinemic,
with reduced glucose-dependent insulin
release from isolated pancreatic islets.
Finally, the Nnt-mutated mice exhibit
reduced Nnt enzymatic activity and de-
creased ATP content in their pancreatic
b cells. Thus, decreased mitochondrial
ATP production in Nnt mutant mice can
account for the impaired glucose homeo-
stasis.
This comprehensive study makes a
compelling case for the proposed mech-
anism of Nnt-impaired secretion. How-
ever, there are additional pieces of infor-
mation that onemight like to see. There is
no direct demonstration that glucose-
dependent regulation of KATP activity is
actually altered, as has been demon-
strated in the case of reduced metabo-
lism in HNF1a-deficient mice (Dukes
et al., 1998). Other mechanisms, such
as reduced ATP sensitivity of KATP chan-
nels, could also cause such an effect.
The current work highlights a role of
Nnt in regulation of insulin release, by a
mechanism that may be common to pro-
teins which directly or indirectly reduce5
P R E V I E W SFigure 1. Glucose-stimulated insulin release from pancreatic b cells
Schematic illustration of the potential role of Nnt in glucose-stimulated insulin secretion (GSIS) from pancreatic
b cells. Glucose entering the b cell is phosphorylated by glucokinase and is metabolized by the glycolytic and
oxidative phosphorylation pathways to produce ATP. A rise in the [ATP]/[ADP] ratio in the cell serves to inhibit
the ATP-sensitive K+ channels (KATP) at the cell surface, causing the membrane to depolarize. Opening of volt-
age-dependent Ca2+ channels (VDCC) results in a rise in intracellular [Ca2+], which stimulates insulin secretion.
Factors that impair ATP production are expected to suppress GSIS. Mutations in several genes that directly or
indirectly alter ATP production and therefore underlie a diabetic phenotype (humans and/or mouse models)
are shown in color: glucokinase (GK), nicotinamide nucleotide transhydrogenase (NNT), uncoupling protein
2 (UCP2), mitochondrial transfer RNA with anticodon UUR (tRNALue). Mutations in KATP result in impaired GSIS
by reducing sensitivity of the channel to [ATP]/[ADP].ATP synthesis. Essentially, mutations of
any enzyme that leads to reduced ATP
synthesis could cause such an effect.
For instance, glucokinase (GK) is a critical
component in b cell glucose metabolism
and phosphorylates glucose in the first,
rate-limiting, step (Figure 1). Homozy-
gous loss-of-function mutations in the
GK gene in humans and GK null mice
both exhibit a severe, neonatal diabetes
(Gloyn et al., 2003; Terauchi et al.,
1995). Conversely, heterozygousGKmu-
tations in humans and heterozygous null
mice both underlie a milder form of dia-
betes (in humans referred to as Maturity
Onset Diabetes of the Young 2, MODY2)
(Gloyn et al., 2003; Terauchi et al., 1995).
A partial loss of glucose-driven ATP pro-
duction underlies the milder phenotype
observed in the heterozygotic state, and
importantly, inhibitors of KATP channels
(i.e., sulfonylureas) can restore insulin re-
lease in this case by circumventing the6metabolic defect and acting directly on
theKATP channels to depolarize themem-
brane and drive Ca2+ into the cell.
Uncoupling proteins (UCPs) dissipate
the proton gradient between the inter-
membrane space and the mitochondrial
matrix to uncouple electron transport
from ATP synthesis. Accumulation of
ROS in the mitochondrial matrix can
increase the activity of uncoupling pro-
tein 2 (UCP2), leading to enhanced pro-
ton leakage across the inner mitochon-
drial membrane and short-circuiting of
proton-motive ATP production. Reminis-
cent ofNntmutantmice, adenoviral over-
expression of UCP2 in rat b cells de-
creases ATP production and therefore
also prevents depolarization-dependent
insulin release (Chan et al., 2001). Inter-
estingly, UCP2 expression is often up-
regulated in animal models of type 2
diabetes (Zhang et al., 2001), and a poly-
morphism in the promoter of the humanUCP2 gene is associated with reduced
insulin secretion and higher frequency
of type 2 diabetes (Sasahara et al., 2004).
Implicit in the conclusions of these
studies is that suppression of insulin re-
lease results from failure to close KATP
channels, and that sulfonylureas, which
inhibit KATP, should be effective thera-
pies. When the diabetes-causing muta-
tions are introduced on a KATP channel
null background, one would predict that
the phenotype should be nullified. One
test of this prediction was recently
made for GK null mice (Remedi et al.,
2005). This study showed that the GK-
deficient diabetic phenotype was signifi-
cantly abrogated on the KATP null back-
ground, but not completely. This raises
the caveat that not all consequences of
reduced metabolism in the b cell may be
attributed to failure to close KATP, leav-
ing open the question of how effective
channel-inhibiting drugswill be in treating
mitochondria-induced diabetes.
Finally, mutations in the mitochondrial
genome give rise to several complex
forms of diabetes, all of which are char-
acterized by oxidative phosphorylation
defects. A point mutation in the mito-
chondrial tRNALeu gene is associated
with maternally inherited early onset dia-
betes and bilateral deafness (van den
Ouweland et al., 1992). Together with the
above studies, and the current contribu-
tion of Freeman and colleagues, these
disparate examples highlight how re-
duced energy-generating capacity can
impair glucose-induced insulin secretion
and contribute to the development of
type 2 diabetes.
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